CN105362410B - 一种治疗烧烫伤的中药制剂及制备方法 - Google Patents
一种治疗烧烫伤的中药制剂及制备方法 Download PDFInfo
- Publication number
- CN105362410B CN105362410B CN201510095869.3A CN201510095869A CN105362410B CN 105362410 B CN105362410 B CN 105362410B CN 201510095869 A CN201510095869 A CN 201510095869A CN 105362410 B CN105362410 B CN 105362410B
- Authority
- CN
- China
- Prior art keywords
- oil
- borneol
- beeswax
- auxiliary material
- kunzhi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 94
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 206010053615 Thermal burn Diseases 0.000 title claims abstract description 28
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 52
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 52
- 229940116229 borneol Drugs 0.000 claims abstract description 52
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 52
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 52
- 235000013871 bee wax Nutrition 0.000 claims abstract description 49
- 239000012166 beeswax Substances 0.000 claims abstract description 49
- 241000382455 Angelica sinensis Species 0.000 claims abstract description 43
- 206010052428 Wound Diseases 0.000 claims abstract description 43
- 208000027418 Wounds and injury Diseases 0.000 claims abstract description 43
- 239000000463 material Substances 0.000 claims abstract description 38
- 241000037740 Coptis chinensis Species 0.000 claims abstract description 37
- 230000035876 healing Effects 0.000 claims abstract description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 101
- 239000002674 ointment Substances 0.000 claims description 61
- 239000003921 oil Substances 0.000 claims description 58
- 235000019198 oils Nutrition 0.000 claims description 58
- 239000000203 mixture Substances 0.000 claims description 46
- 239000000341 volatile oil Substances 0.000 claims description 34
- 239000000706 filtrate Substances 0.000 claims description 27
- 239000007788 liquid Substances 0.000 claims description 27
- 239000007864 aqueous solution Substances 0.000 claims description 25
- 239000002994 raw material Substances 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 25
- 238000003756 stirring Methods 0.000 claims description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 241000125175 Angelica Species 0.000 claims description 22
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 22
- 229920006395 saturated elastomer Polymers 0.000 claims description 22
- 239000000284 extract Substances 0.000 claims description 16
- 239000000796 flavoring agent Substances 0.000 claims description 15
- 235000019634 flavors Nutrition 0.000 claims description 15
- 230000002829 reductive effect Effects 0.000 claims description 13
- 239000002244 precipitate Substances 0.000 claims description 12
- 239000008159 sesame oil Substances 0.000 claims description 11
- 235000011803 sesame oil Nutrition 0.000 claims description 11
- 241000218202 Coptis Species 0.000 claims description 10
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 10
- 208000015181 infectious disease Diseases 0.000 claims description 10
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 6
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 6
- 229920002752 Konjac Polymers 0.000 claims description 6
- 239000000252 konjac Substances 0.000 claims description 6
- 235000010485 konjac Nutrition 0.000 claims description 6
- 240000008415 Lactuca sativa Species 0.000 claims description 5
- 239000004359 castor oil Substances 0.000 claims description 5
- 235000019438 castor oil Nutrition 0.000 claims description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 5
- 235000008390 olive oil Nutrition 0.000 claims description 5
- 239000004006 olive oil Substances 0.000 claims description 5
- 235000012045 salad Nutrition 0.000 claims description 5
- 238000004821 distillation Methods 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000002671 adjuvant Substances 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 238000001556 precipitation Methods 0.000 claims 1
- 238000003809 water extraction Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 19
- 210000004369 blood Anatomy 0.000 abstract description 17
- 239000008280 blood Substances 0.000 abstract description 17
- 208000002193 Pain Diseases 0.000 abstract description 14
- 230000036407 pain Effects 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 10
- 206010048038 Wound infection Diseases 0.000 abstract description 8
- 210000003205 muscle Anatomy 0.000 abstract description 8
- 230000008961 swelling Effects 0.000 abstract description 6
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 3
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 238000012795 verification Methods 0.000 abstract description 3
- 230000001172 regenerating effect Effects 0.000 abstract description 2
- 238000012360 testing method Methods 0.000 description 30
- 229940079593 drug Drugs 0.000 description 29
- 210000003491 skin Anatomy 0.000 description 29
- 241000699670 Mus sp. Species 0.000 description 21
- 239000009416 jing wan hong Substances 0.000 description 16
- 238000011282 treatment Methods 0.000 description 16
- 241001465754 Metazoa Species 0.000 description 13
- 239000002552 dosage form Substances 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- 231100000614 poison Toxicity 0.000 description 11
- 239000012141 concentrate Substances 0.000 description 10
- 238000012545 processing Methods 0.000 description 10
- 241000700159 Rattus Species 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 230000029663 wound healing Effects 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 7
- 238000010998 test method Methods 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- 241000512259 Ascophyllum nodosum Species 0.000 description 6
- 206010061218 Inflammation Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000004054 inflammatory process Effects 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 230000006378 damage Effects 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- -1 iodine amines Chemical class 0.000 description 5
- 208000011580 syndromic disease Diseases 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 239000003053 toxin Substances 0.000 description 5
- 231100000765 toxin Toxicity 0.000 description 5
- 241000700198 Cavia Species 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 4
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 4
- 238000011047 acute toxicity test Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 210000003780 hair follicle Anatomy 0.000 description 4
- 230000001338 necrotic effect Effects 0.000 description 4
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 230000037311 normal skin Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 230000000699 topical effect Effects 0.000 description 4
- 239000003981 vehicle Substances 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- 241000700199 Cavia porcellus Species 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 3
- 108010000912 Egg Proteins Proteins 0.000 description 3
- 229910000831 Steel Inorganic materials 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000003285 pharmacodynamic effect Effects 0.000 description 3
- 230000007096 poisonous effect Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 239000010959 steel Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 210000003462 vein Anatomy 0.000 description 3
- 210000001835 viscera Anatomy 0.000 description 3
- 206010067484 Adverse reaction Diseases 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 206010014025 Ear swelling Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 2
- 208000000114 Pain Threshold Diseases 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 206010048629 Wound secretion Diseases 0.000 description 2
- 230000006838 adverse reaction Effects 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 238000011888 autopsy Methods 0.000 description 2
- 208000022362 bacterial infectious disease Diseases 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000001276 controlling effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000004089 microcirculation Effects 0.000 description 2
- 230000037040 pain threshold Effects 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 231100000241 scar Toxicity 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 229960003600 silver sulfadiazine Drugs 0.000 description 2
- UEJSSZHHYBHCEL-UHFFFAOYSA-N silver(1+) sulfadiazinate Chemical compound [Ag+].C1=CC(N)=CC=C1S(=O)(=O)[N-]C1=NC=CC=N1 UEJSSZHHYBHCEL-UHFFFAOYSA-N 0.000 description 2
- 235000014347 soups Nutrition 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000008096 xylene Substances 0.000 description 2
- 241000272525 Anas platyrhynchos Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010006802 Burns second degree Diseases 0.000 description 1
- COXVTLYNGOIATD-HVMBLDELSA-N CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O Chemical compound CC1=C(C=CC(=C1)C1=CC(C)=C(C=C1)\N=N\C1=C(O)C2=C(N)C(=CC(=C2C=C1)S(O)(=O)=O)S(O)(=O)=O)\N=N\C1=CC=C2C(=CC(=C(N)C2=C1O)S(O)(=O)=O)S(O)(=O)=O COXVTLYNGOIATD-HVMBLDELSA-N 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 206010069808 Electrical burn Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 240000001624 Espostoa lanata Species 0.000 description 1
- 235000009161 Espostoa lanata Nutrition 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 206010072170 Skin wound Diseases 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000002565 arteriole Anatomy 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 235000019606 astringent taste Nutrition 0.000 description 1
- 230000000157 blood function Effects 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 230000004856 capillary permeability Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 229960003699 evans blue Drugs 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000002360 explosive Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 210000003108 foot joint Anatomy 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 239000010015 huanglian Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 238000011031 large-scale manufacturing process Methods 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 230000008338 local blood flow Effects 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000037390 scarring Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000009528 severe injury Effects 0.000 description 1
- 231100000075 skin burn Toxicity 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 230000036575 thermal burns Effects 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims (17)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510095869.3A CN105362410B (zh) | 2015-03-04 | 2015-03-04 | 一种治疗烧烫伤的中药制剂及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510095869.3A CN105362410B (zh) | 2015-03-04 | 2015-03-04 | 一种治疗烧烫伤的中药制剂及制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105362410A CN105362410A (zh) | 2016-03-02 |
CN105362410B true CN105362410B (zh) | 2020-02-28 |
Family
ID=55365364
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510095869.3A Active CN105362410B (zh) | 2015-03-04 | 2015-03-04 | 一种治疗烧烫伤的中药制剂及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105362410B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113509493B (zh) * | 2020-04-09 | 2024-01-30 | 大连麦琪克生物技术有限公司 | 一种促创面愈合的抑菌软膏及其制备方法 |
CN115068528B (zh) * | 2021-03-16 | 2024-09-13 | 扬子江药业集团江苏龙凤堂中药有限公司 | 一种中药组合物在制备治疗糖尿病性皮肤溃疡药物的应用 |
CN115068529B (zh) * | 2021-03-16 | 2024-09-13 | 扬子江药业集团江苏龙凤堂中药有限公司 | 一种中药组合物在制备治疗压疮皮肤溃疡药物的应用 |
KR20230157449A (ko) * | 2021-03-16 | 2023-11-16 | 양쯔리버 파마슈티칼 그룹 컴퍼니 리미티드 | 만성 피부 궤양의 예방 또는 치료용 약물 제조에서 중약 조성물의 용도 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1546116A (zh) * | 2003-12-16 | 2004-11-17 | 南京生物工程与医药科技发展有限公司 | 治疗偏头痛的中药组合物及其制备方法 |
CN1733048A (zh) * | 2005-07-29 | 2006-02-15 | 王衡新 | 理气化痰祛风和胃的中药制剂及其制备方法 |
-
2015
- 2015-03-04 CN CN201510095869.3A patent/CN105362410B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1546116A (zh) * | 2003-12-16 | 2004-11-17 | 南京生物工程与医药科技发展有限公司 | 治疗偏头痛的中药组合物及其制备方法 |
CN1733048A (zh) * | 2005-07-29 | 2006-02-15 | 王衡新 | 理气化痰祛风和胃的中药制剂及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN105362410A (zh) | 2016-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105362410B (zh) | 一种治疗烧烫伤的中药制剂及制备方法 | |
CN102743662B (zh) | 治疗妇科炎症的壮药制剂及其制备方法 | |
CN103611084B (zh) | 一种治疗疮疖药膏及其制备方法 | |
JP2021516696A (ja) | 漢方薬組成物、漢方薬配合製剤及びその調製方法と応用 | |
CN104906466B (zh) | 一种桉叶乳膏及其制备方法 | |
CN103263451B (zh) | 一种主治外伤、疮疡的中药及其制备方法和应用 | |
CN106822321B (zh) | 伤科黄水在制备治疗毛周角化症的药物中的应用 | |
CN104225386A (zh) | 一种高效低毒的复方雷公藤凝胶膏及其制备方法 | |
CN104000919B (zh) | 一种中药组合物 | |
CN107648444A (zh) | 一种用于外阴脂溢性皮炎的缓释性透皮给药贴 | |
CN103816486B (zh) | 一种治疗急慢性肝炎的中药制剂 | |
CN103316177B (zh) | 一种活血化瘀、消炎止痛膏及其制备方法 | |
CN107213250B (zh) | 一种用于防治类风湿关节炎的中药组合物及其制备方法 | |
CN107812091B (zh) | 一种治疗化疗药物引起的静脉炎的中药制剂及其制备方法 | |
CN104352599A (zh) | 一种治疗烧烫伤的中药组合物 | |
CN114886981B (zh) | 中药组合物及其在制备颈肩腰腿痛药中的应用 | |
CN100344311C (zh) | 治疗荨麻疹和皮肤瘙痒症的中药组合物及其制备方法 | |
CN107468870A (zh) | 一种用于治疗皮炎的软膏剂药物及其制备方法 | |
CN111671883B (zh) | 一种配合灸疗治疗溃疡性结肠炎的中药组合物及其制备方法和应用 | |
CN104784541B (zh) | 一种用于去除粉刺的中药药剂及其制备方法 | |
CN101869668B (zh) | 一种治疗烧烫伤的涂膜剂及其制备方法 | |
CN104800629B (zh) | 一种消刺膏及其制备方法 | |
CN1453031A (zh) | 一种治疗乳腺增生病的外用药组合物及其制备方法 | |
CN118001354A (zh) | 一种治疗皮肤癣病的中药组合物及其应用 | |
CN112439006A (zh) | 一种治疗顽固性神经性皮炎的中药组合物、酊剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200521 Address after: 225321 No. 1 Jiangnan Road, Taizhou high port district, Jiangsu, China Co-patentee after: YANGTZE RIVER PHARMACEUTICAL GROUP JIANGSU PHARMACEUTICAL STOCK Co.,Ltd. Patentee after: YANGTZE RIVER PHARMACEUTICAL GROUP Co.,Ltd. Co-patentee after: YANGZIJIANG PHARMACEUTICAL GROUP JIANGSU LONGFENGTANG TRADITIONAL CHINESE MEDICINE Co.,Ltd. Address before: Xinluo Avenue high tech Zone of Ji'nan City, Shandong Province, No. 989 250101 Patentee before: INSTITUTE OF BIOPHARMACEUTICALS OF SHANDONG PROVINCE |
|
TR01 | Transfer of patent right |